REUTERS Jun 3, 2023, 04:15 PM EDT (Reuters) -Cancer test maker Grail Inc said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer. Grail’s flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear. The company,...